Laura Castex

Gide Loyrette Nouel (Paris)
Lawyer (Partner)

Laura Castex is a partner with Gide Loyrette Nouel in Paris. Admitted to the Paris Bar in 2006, she specialises in European and French competition law as well as distribution law (distribution networks, commercial agreements, etc.) and consumer law, both in an advisory capacity and as a litigator. As regards merger control, Laura advises major French and foreign firms for their investments and divestments, including in non-EU jurisdictions. As regards anticompetitive practices, Laura has extensive experience in investigation proceedings and the design of bespoke compliance programs (private enforcement). She also assists our clients in private enforcement litigation. Lastly, as regards distribution and consumer law, Laura regularly advises our clients in the formalisation of their commercial relations and in litigation arising from them, as well as in the context of investigations carried out by the Directorate-General for Competition, Consumer Affairs and Prevention of Fraud (DGCCRF) and its local branches.

Auteurs associés

Gide Loyrette Nouel (Brussels)
Gide Loyrette Nouel (Paris)
Gide Loyrette Nouel (Brussels)
Gide Loyrette Nouel (Brussels)
Gide Loyrette Nouel (Brussels)


24201 Bulletin

Laura Castex The French Supreme Administrative Court upholds the Competition Authority’s decision sanctioning a food distributor for failing to notify a concentration (Colruyt)


On 24 June 2013, the French Supreme Administrative Court confirmed the French Competition Authority (“FCA”)‘s decision n°12-D-12 dated 11 May 2012 imposing a €392.000 fine on Etablissements Fr. Colruyt (“Ets Fr Colruyt”), the parent company of group Colruyt, for failing to comply with article L.430-3 (...)

Laura Castex The French Competition Council authorises pharmaceutical laboratories’ practices concerning drugs parallell imports and exports on the basis of both French and EC provisions (Pharma-Lab / GlaxoSmithKline)


Pharma-Lab, Pharmajet, Pharmadex TMC, European Trade Company (ETC) and AD Pharm export drugs bought at the government-fixed price from pharmaceutical laboratories and sell them abroad for a higher price. These companies claimed to suffer from delivery restrictions, discriminatory commercial (...)

Laura Castex The French Competition Authority imposes record fines on the mobile telephone operators for market sharing and exchange of information (Orange / SFR / Bouygues)


On November 30th 2005, the French Competition Council (the “Council” ) imposed heavy fines on the three mobile telephone undertakings, Orange France, SFR and Bouygues Telecom, amounting to a € 534 millions total. The allotment of the fines was as follows : Orange France : 256 million Euros SFR : (...)

778 Revue

Envoyer un message